249 related articles for article (PubMed ID: 8950984)
21. Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats.
Cowin AJ; Kallincos N; Hatzirodos N; Robertson JG; Pickering KJ; Couper J; Belford DA
Cell Tissue Res; 2001 Nov; 306(2):239-50. PubMed ID: 11702235
[TBL] [Abstract][Full Text] [Related]
22. The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein.
Wang MH; Iwama A; Skeel A; Suda T; Leonard EJ
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3933-7. PubMed ID: 7732008
[TBL] [Abstract][Full Text] [Related]
23. Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages.
Morrison AC; Correll PH
J Immunol; 2002 Jan; 168(2):853-60. PubMed ID: 11777982
[TBL] [Abstract][Full Text] [Related]
24. Macrophage-stimulating protein (MSP) and its receptor, RON, stimulate human osteoclast activity but not proliferation: effect of MSP distinct from that of hepatocyte growth factor.
Kurihara N; Tatsumi J; Arai F; Iwama A; Suda T
Exp Hematol; 1998 Oct; 26(11):1080-5. PubMed ID: 9766449
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member.
O'Toole JM; Rabenau KE; Burns K; Lu D; Mangalampalli V; Balderes P; Covino N; Bassi R; Prewett M; Gottfredsen KJ; Thobe MN; Cheng Y; Li Y; Hicklin DJ; Zhu Z; Waltz SE; Hayman MJ; Ludwig DL; Pereira DS
Cancer Res; 2006 Sep; 66(18):9162-70. PubMed ID: 16982759
[TBL] [Abstract][Full Text] [Related]
26. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
Peace BE; Hughes MJ; Degen SJ; Waltz SE
Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
[TBL] [Abstract][Full Text] [Related]
27. Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages.
Zhou YQ; Chen YQ; Fisher JH; Wang MH
J Biol Chem; 2002 Oct; 277(41):38104-10. PubMed ID: 12177064
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic signaling pathways activated by RON receptor tyrosine kinase.
Danilkovitch-Miagkova A
Curr Cancer Drug Targets; 2003 Feb; 3(1):31-40. PubMed ID: 12570659
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic cleavage and activation of pro-macrophage-stimulating protein and upregulation of its receptor in tissue injury.
Nanney LB; Skeel A; Luan J; Polis S; Richmond A; Wang MH; Leonard EJ
J Invest Dermatol; 1998 Oct; 111(4):573-81. PubMed ID: 9764835
[TBL] [Abstract][Full Text] [Related]
30. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
Morrison AC; Wilson CB; Ray M; Correll PH
J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the RON receptor tyrosine kinase expression in macrophages: blocking the RON gene transcription by endotoxin-induced nitric oxide.
Wang MH; Fung HL; Chen YQ
J Immunol; 2000 Apr; 164(7):3815-21. PubMed ID: 10725742
[TBL] [Abstract][Full Text] [Related]
32. Proteolytic activation of pro-macrophage-stimulating protein by hepsin.
Ganesan R; Kolumam GA; Lin SJ; Xie MH; Santell L; Wu TD; Lazarus RA; Chaudhuri A; Kirchhofer D
Mol Cancer Res; 2011 Sep; 9(9):1175-86. PubMed ID: 21875933
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
Wang MH; Wang D; Chen YQ
Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
[TBL] [Abstract][Full Text] [Related]
34. The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration.
Santoro MM; Gaudino G; Marchisio PC
Dev Cell; 2003 Aug; 5(2):257-71. PubMed ID: 12919677
[TBL] [Abstract][Full Text] [Related]
35. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
Park JS; Park JH; Khoi PN; Joo YE; Jung YD
Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of RON-mediated epithelial-mesenchymal transition in MDCK cells through the MAPK pathway.
Xiangming X; Yun Q; Guoliang Z; Jianjiang L; Lisong T
Braz J Med Biol Res; 2011 Jul; 44(7):634-41. PubMed ID: 21655705
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein.
Ray M; Yu S; Sharda DR; Wilson CB; Liu Q; Kaushal N; Prabhu KS; Hankey PA
J Immunol; 2010 Dec; 185(12):7309-16. PubMed ID: 21078906
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
[TBL] [Abstract][Full Text] [Related]
39. Requirement of both tyrosine residues 1330 and 1337 in the C-terminal tail of the RON receptor tyrosine kinase for epithelial cell scattering and migration.
Xiao ZQ; Chen YQ; Wang MH
Biochem Biophys Res Commun; 2000 Jan; 267(2):669-75. PubMed ID: 10631120
[TBL] [Abstract][Full Text] [Related]
40. Macrophage-stimulating protein is produced by tubular cells and activates mesangial cells.
Rampino T; Collesi C; Gregorini M; Maggio M; Soccio G; Guallini P; Canton AD
J Am Soc Nephrol; 2002 Mar; 13(3):649-657. PubMed ID: 11856768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
